Search Results - "Ince, Will"
-
1
Combination therapies in clinical trials for renal cell carcinoma: how could they impact future treatments?
Published in Expert opinion on investigational drugs (02-12-2021)“…Pharmacological combinations using immune checkpoint inhibition (ICI), tyrosine kinase inhibition (TKIs), and mammalian target of rapamycin inhibitors (mTOR)…”
Get more information
Journal Article -
2
What is the role of real-world data in metastatic renal cell cancer?
Published in Future oncology (London, England) (01-10-2021)Get full text
Journal Article -
3
Spleen as an organ at risk in lower lobe lung tumours treated with radical radiotherapy
Published in Lung cancer (Amsterdam, Netherlands) (01-03-2022)Get full text
Journal Article -
4
129 - Spleen as an organ at risk in lower lobe lung tumours treated with radical radiotherapy
Published in Lung cancer (Amsterdam, Netherlands) (01-03-2022)Get full text
Journal Article -
5
Apalutamide toxicity and tolerability: A real-world multicentre experience in metastatic hormone-sensitive prostate cancer (MHSPC) in the United Kingdom (UK)
Published in Journal of clinical oncology (01-02-2024)“…107 Background: Apalutamide became available for mHSPC along with androgen deprivation treatment (ADT) in the UK in November 2021. We present here, to our best…”
Get full text
Journal Article -
6
Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis
Published in Current oncology reports (20-11-2024)“…Abstract Purpose of Review In this review, we discuss which patients with metastatic clear cell renal cell carcinoma (mRCC) may be most suitable for frontline…”
Get full text
Journal Article -
7
Treatment outcomes and locoregional recurrence in head and neck cancer
Published in Royal College of Radiologists Open (01-12-2023)Get full text
Journal Article